🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates how well panitumumab-IRDye800 and 89Zr-panitumumab wor...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-01-07
Trial ID
NCT03733210
Treatments Being Tested
This phase I trial evaluates the safety and effectiveness of using two imag...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-10-03
Trial ID
NCT05945875
This phase 2 trial studies how well panitumumab-IRDye800 works in identifyi...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2019-08-01
Trial ID
NCT03405142
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of panitumumab...
Status
Recruiting
Location
Stanford University, School of Medicine
Start Date
2018-02-07
Trial ID
NCT03384238
Treatments Being Tested
This pilot clinical study evaluates the safety and imaging performance of p...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2026-07
Trial ID
NCT07493447
Treatments Being Tested
The phase I/II trial studies the side effects and best dose of panitumumab-...
Status
Recruiting
Location
Stanford University School of Medicine
Start Date
2018-05-16
Trial ID
NCT03510208
Treatments Being Tested
Phase I trial to evaluate the safety of escalating dose levels of conjugate...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-08
Trial ID
NCT02415881
Treatments Being Tested
The goal of this clinical trial is to learn whether using two imaging agent...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07741643
Treatments Being Tested
The purpose of this study is to determine if panitumumab-IRDye800 is effect...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-04-02
Trial ID
NCT04511078
Treatments Being Tested
This phase I/II trial studies the best dose and timing of panitumumab-IRDye...
Status
Recruiting
Location
Stanford University, School of Medicine
Start Date
2018-07-19
Trial ID
NCT03582124